Last deal

$45.3M
Local Amount - EUR 40M

Amount

Series C

Stage

20.01.2022

Date

5

all rounds

$75.1M

Total amount

General

About Company
Wandercraft develops and sells the first exoskeleton to walk self-balanced, providing a realistic gait without crutches or technical aids.

Industry

Sector :

Subsector :

founded date

10.10.2012

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Wandercraft is a full-stack company that integrates competencies in algorithmics, AI, robotics, production, clinical, marketing, and sales to develop and distribute self-balancing, hands-free walking exoskeletons for inpatient rehab and outpatient daily life. Their first commercial version, Atalante, is sold to European rehab hospitals to improve gait re-learning treatments, and FDA approval is on the way. Wandercraft also develops a slimmer, sleeker, and agile Personal Mobility exo for daily life usage. The company's exoskeletons use robotic technologies and engage in the distribution of motored legs exoskeletons, enabling paraplegics and myopathic people to get autonomy during daily activity. Wandercraft's mission is to make wheelchair users walk again and provide an ordinary life to extraordinary people. They cooperate with world-class university labs and medical centers in Europe and the US and have made 546 patients smile again with Atalante. Wandercraft is a challenging, fast-paced, and perfection-driven company that aims to change the lives of millions of persons.
Contacts

Phone number

Social url